Citadel Advisors’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.23M | Sell |
|
|||||
|
2025
Q1 | $1.42M | Buy |
|
|||||
|
2024
Q4 | $729K | Sell |
|
|||||
|
2024
Q3 | $3.61M | Buy |
|
|||||
|
2024
Q2 | $2.48M | Sell |
|
|||||
|
2024
Q1 | $15.6M | Buy |
|
|||||
|
2023
Q4 | $6.27M | Buy |
|
|||||
|
2023
Q3 | $3.15M | Sell |
|
|||||
|
2023
Q2 | $13.1M | Buy |
|
|||||
|
2023
Q1 | $6.13M | Buy |
|
|||||
|
2022
Q4 | $713K | Sell |
|
|||||
|
2022
Q3 | $2.43M | Sell |
|
|||||
|
2022
Q2 | $16.5M | Buy |
|
|||||
|
2022
Q1 | $22.4M | Buy |
|
|||||
|
2021
Q4 | $20.2M | Sell |
|
|||||
|
2021
Q3 | $30.5M | Sell |
|
|||||
|
2021
Q2 | $48.7M | Buy |
|